Peri-procedural tight glycemic control during early percutaneous coronary intervention is associated with a lower rate of in-stent restenosis in patients with acute ST-elevation myocardial infarction

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 8, 2012, Pages 2862-2871

  Marfella, Raffaele ^a   Sasso, Ferdinando Carlo ^a   Siniscalchi, Mario ^b   Paolisso, Pasquale ^a   Rizzo, Maria Rosaria ^a   Ferraro, Fausto ^a   Stabile, Eugenio ^c   Sorropago, Giovanni ^c   Calabrò, Paolo ^a   Carbonara, Ornella ^a   Cinquegrana, Giorgio ^b   Piscione, Federico ^d   Ruocco, Antonio ^b   D'Andrea, Davide ^b   Rapacciuolo, Antonio ^d   Petronella, Pasquale ^a   Bresciani, Alessandro ^b   Rubino, Paolo ^c   Mauro, Ciro ^b   Paolisso, Giuseppe ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

^c Clinica Montevergine   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ACARBOSE; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN DERIVATIVE; INSULIN GLARGINE; METFORMIN; MONOCOMPONENT INSULIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PIOGLITAZONE; SHORT ACTING INSULIN; SULFACARBAMIDE; THIAZIDE DIURETIC AGENT;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CONTINUOUS INFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EVENING DOSAGE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; IN-STENT RESTENOSIS; INFLAMMATION; INSULIN INFUSION; MAJOR CLINICAL STUDY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ANGIOPLASTY, BALLOON, CORONARY; BLOOD GLUCOSE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; ELECTROCARDIOGRAPHY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; STENTS;

EID: 84864826554     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1364     Document Type: Article

References (32)

1. Timmer JR, Ottervanger JP, de Boer MJ, Boersma E, Grines CL, Westerhout CM, Simes RJ, Granger CB, Zijlstra F 2007 Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs. Thrombolysis-2 trial. Arch Intern Med 167:1353-1359 (Pubitemid 47052432)
2. Corpus RA, George PB, House JA, Dixon SR, Ajluni SC, Devlin WH, Timmis GC, Balasubramaniam M, O'Neill WW 2004 Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 43:8-14 (Pubitemid 38045906)
3. Lindsay J, Sharma AK, Canos D, Nandalur M, Pinnow E, Apple S, Ruotolo G, Wijetunga M, Waksman R 2007 Preprocedure hyperglycemia is more strongly associated with restenosis in diabetic patients after percutaneous coronary intervention than is hemoglobin A1C. Cardiovasc Revasc Med 8:15-20 (Pubitemid 46216178)
4. Mitra AK, Agrawal DK 2006 In stent restenosis: bane of the stent era. J Clin Pathol 59:232-239 (Pubitemid 43344881)
5. Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R 2010 In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol 56:1897-1907
6. Stein B, Weintraub WS, Gebhart SP, Cohen-Bernstein CL, Gross-wald R, Liberman HA, Douglas Jr JS, Morris DC, King 3rd SB 1995 Influence of diabetes mellitus on early and late outcome after percutaneous transmural coronary angioplasty. Circulation 91:979-989
7. Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, Paloscia L, Materazzo G, D'Annunzio E, Conti P, Chiarelli F, Cuccurullo F, Mezzetti A 2001 Elevated circulating levels of monocyte chemo-attractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 21:327-334 (Pubitemid 32199112)
8. Cooper ME, El-Osta A 2010 Epigenetics: mechanisms and implications for diabetic complications. Circ Res 107:1403-1413
9. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P 2008 American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117:1610-1619 (Pubitemid 351440650)
10. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M 2008 ESC Committee for Practice Guidelines (CPG). 4. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29:2909-2945
11. Chan PS, Patel MR, Klein LW, Krone RJ, Dehmer GJ, Kennedy K, Nallamothu BK, Weaver WD, Masoudi FA, Rumsfeld JS, Brindis RG, Spertus JA 2011 Appropriateness of percutaneous coronary intervention. JAMA 306:53-61
12. Cutlip DE, Chhabra AG, Baim DS, Chauhan MS, Marulkar S, Massaro J, Bakhai A, Cohen DJ, Kuntz RE, Ho KK 2004 Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation 110:1226-1230 (Pubitemid 39202337)
13. Ceriello A, Ihnat MA, Thorpe JE 2009 Clinical review 2. The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab 94:410-415
14. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group 2000 Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 342:381-389
15. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group 2003 Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290:2159-2167
16. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M 2008 Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 205:2409-2417
17. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi H, Ohishi H 1988 Restenosis after successful percutaneous transluminal angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 12:616-623
18. Maehara A, Mintz GS, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett Jr MA, Parise H, Mehran R, Stone GW 2009 Volumetric intravascular ultrasound analysis of paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy. Circulation 120:1875-1882
19. Iijima R, Byrne RA, Dibra A, Ndrepepa G, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Suttorp MJ, Violini R, Schömig A, Kastrati A 2009 Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials. Rev Esp Cardiol 62:354-364
20. Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R 2002 Morphological predictors of restenosis after coronary stenting in humans. Circulation 105:2974-2980 (Pubitemid 34693829)
21. Marfella R, Di Filippo C, Esposito K, Nappo F, Piegari E, Cuzzocrea S, Berrino L, Rossi F, Giugliano D, D'Amico M 2004 Absence of inducible nitric oxide synthase reduces myocardial damage during ischemia reperfusion in streptozotocin-induced hyperglycemic mice. Diabetes 53:454-462 (Pubitemid 38174563)
22. Beckman JS, Koppenol WH 1996 Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-C1437
23. Takahara N, Kashiwagi A, Nishio Y, Harada N, Kojima H, Maegawa H, Hidaka H, Kikkawa R 1997 Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells. Diabetologia 40:662-670 (Pubitemid 27288111)
24. Ohtani K, Usui M, Nakano K, Kohjimoto Y, Kitajima S, Hirouchi Y, Li XH, Kitamoto S, Takeshita A, Egashira K 2004 Antimonocyte chemoattractant protein-1 gene therapy reduces experimental instent restenosis in hypercholesterolemic rabbits and monkeys. Gene Ther 11:1273-1282 (Pubitemid 39173434)
25. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S 2001 Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 86:3257-3265 (Pubitemid 32674120)
26. Chaudhuri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyopadhyay A, Calieri J, Hoffmeyer D, Syed T, Ghanim H, Aljada A, Dandona P 2004 Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 109:849-854 (Pubitemid 38252736)
27. Kwoun MO, Ling PR, Lydon E, Imrich A, Qu Z, Palombo J, Bistrian BR1997 Immunologic effects of acute hyperglycemia in nondiabetic rats. JPEN J Parenter Enteral Nutr 21:91-95 (Pubitemid 27136782)
28. Morisco C, Marrone C, Trimarco V, Crispo S, Monti MG, Sadoshima J, Trimarco B 2007 Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression. Cardiovasc Res 76:453-464 (Pubitemid 350007455)
29. Opie LH 2008 Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia. Circulation 117:2172-2177
30. Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenström A; DIGAMI 2 Investigators 2005 Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26:650-661
31. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R 2001 Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367
32. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P 2003 Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31:359-366 (Pubitemid 36232926)